Literature DB >> 22560676

Neurocognitive deficits are associated with unemployment in chronic methamphetamine users.

Erica Weber1, Kaitlin Blackstone, Jennfer E Iudicello, Erin E Morgan, Igor Grant, David J Moore, Steven Paul Woods.   

Abstract

BACKGROUND: Unemployment rates are high among chronic methamphetamine (MA) users and carry a significant economic burden, yet little is known about the neurocognitive and psychiatric predictors of employment in this vulnerable population.
METHODS: The present study examined this issue in 63 participants with recent MA dependence and 47 comparison subjects without histories of MA use disorders. All participants completed a comprehensive neurocognitive, psychiatric and neuromedical evaluation. Individuals with HIV infection, severe neuropsychological or psychiatric conditions that might affect cognition (e.g., seizure disorder, schizophrenia), or a positive Breathalyzer or urine toxicology screen on the day of testing were excluded.
RESULTS: Consistent with previous research, a logistic regression revealed MA dependence as a significant, independent predictor of full-time unemployment status. Within the MA-dependent sample, greater impairment in global neurocognitive functioning and history of injection drug use emerged as significant independent predictors of unemployment status. The association between worse global cognitive functioning and unemployment was primarily driven by deficits in executive functions, learning, verbal fluency, and working memory.
CONCLUSION: These findings indicate that neurocognitive deficits play a significant role in the higher unemployment rates of MA-dependent individuals, and highlight the need for vocational rehabilitation and supported employment programs that assess and bolster cognitive skills in this population.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22560676      PMCID: PMC3735422          DOI: 10.1016/j.drugalcdep.2012.04.002

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  52 in total

1.  UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

Authors:  T L Patterson; S Goldman; C L McKibbin; T Hughs; D V Jeste
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

2.  Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study.

Authors:  Igor Grant; Raul Gonzalez; Catherine L Carey; Loki Natarajan; Tanya Wolfson
Journal:  J Int Neuropsychol Soc       Date:  2003-07       Impact factor: 2.892

3.  Measuring employment among substance-using offenders.

Authors:  J Matthew Webster; Michele Staton-Tindall; Jamieson L Duvall; Thomas F Garrity; Carl G Leukefeld
Journal:  Subst Use Misuse       Date:  2007       Impact factor: 2.164

4.  High-risk behaviors associated with injection drug use among recently HIV-infected men who have sex with men in San Diego, CA.

Authors:  Angie Ghanem; Susan J Little; Lydia Drumright; Lin Liu; Sheldon Morris; Richard S Garfein
Journal:  AIDS Behav       Date:  2011-10

5.  Neurocognitive deficits in cocaine users: a quantitative review of the evidence.

Authors:  Diana Jovanovski; Suzanne Erb; Konstantine K Zakzanis
Journal:  J Clin Exp Neuropsychol       Date:  2005-02       Impact factor: 2.475

6.  A comparison of injection and non-injection methamphetamine-using HIV positive men who have sex with men.

Authors:  Shirley J Semple; Thomas L Patterson; Igor Grant
Journal:  Drug Alcohol Depend       Date:  2004-11-11       Impact factor: 4.492

7.  Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity.

Authors:  Buyean Lee; Edythe D London; Russell A Poldrack; Judah Farahi; Angelo Nacca; John R Monterosso; Jeanette A Mumford; Andrew V Bokarius; Magnus Dahlbom; Jogeshwar Mukherjee; Robert M Bilder; Arthur L Brody; Mark A Mandelkern
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

Review 8.  Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.

Authors:  Linda Chang; Daniel Alicata; Thomas Ernst; Nora Volkow
Journal:  Addiction       Date:  2007-04       Impact factor: 6.526

9.  The effect of relapse on cognition in abstinent methamphetamine abusers.

Authors:  Sara L Simon; Jennifer Dacey; Susan Glynn; Richard Rawson; Walter Ling
Journal:  J Subst Abuse Treat       Date:  2004-07

10.  Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection.

Authors:  Catherine L Carey; Steven Paul Woods; Julie D Rippeth; Raul Gonzalez; Robert K Heaton; Igor Grant
Journal:  AIDS Behav       Date:  2006-03
View more
  33 in total

1.  Methamphetamine dependent individuals show attenuated brain response to pleasant interoceptive stimuli.

Authors:  April C May; Jennifer L Stewart; Robyn Migliorini; Susan F Tapert; Martin P Paulus
Journal:  Drug Alcohol Depend       Date:  2013-06-25       Impact factor: 4.492

2.  Attention-deficit/hyperactivity disorder among chronic methamphetamine users: frequency, persistence, and adverse effects on everyday functioning.

Authors:  Lisa C Obermeit; Jordan E Cattie; Khalima A Bolden; Maria J Marquine; Erin E Morgan; Donald R Franklin; J Hampton Atkinson; Igor Grant; Steven Paul Woods
Journal:  Addict Behav       Date:  2013-08-19       Impact factor: 3.913

3.  Dynamic indices of methamphetamine dependence and HIV infection predict fluctuations in affective distress: a five-year longitudinal analysis.

Authors:  Jessica L Montoya; Anya Umlauf; Ian Abramson; Jayraan Badiee; Steven Paul Woods; J Hampton Atkinson; Igor Grant; David J Moore
Journal:  J Affect Disord       Date:  2013-08-16       Impact factor: 4.839

4.  Apathy is associated with white matter abnormalities in anterior, medial brain regions in persons with HIV infection.

Authors:  Rujvi Kamat; Gregory G Brown; Khalima Bolden; Christine Fennema-Notestein; Sarah Archibald; Thomas D Marcotte; Scott L Letendre; Ronald J Ellis; Steven Paul Woods; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2014-10-02       Impact factor: 2.475

5.  Self-reported cognitive scales in a US National Survey: reliability, validity, and preliminary evidence for associations with alcohol and drug use.

Authors:  Efrat Aharonovich; Dvora Shmulewitz; Melanie M Wall; Bridget F Grant; Deborah S Hasin
Journal:  Addiction       Date:  2017-07-31       Impact factor: 6.526

6.  Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection.

Authors:  Erica Weber; Erin E Morgan; Jennifer E Iudicello; Kaitlin Blackstone; Igor Grant; Ronald J Ellis; Scott L Letendre; Susan Little; Sheldon Morris; Davey M Smith; David J Moore; Steven Paul Woods
Journal:  J Neurovirol       Date:  2012-12-19       Impact factor: 2.643

7.  Substance use and mental health characteristics associated with cognitive functioning among adults who use methamphetamine.

Authors:  Diane M Herbeck; Mary-Lynn Brecht
Journal:  J Addict Dis       Date:  2013

8.  "Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency.

Authors:  María J Marquine; Jennifer E Iudicello; Erin E Morgan; Gregory G Brown; Scott L Letendre; Ronald J Ellis; Reena Deutsch; Steven Paul Woods; Igor Grant; Robert K Heaton
Journal:  Psychiatry Res       Date:  2013-11-13       Impact factor: 3.222

9.  Time-based prospective memory predicts engagement in risk behaviors among substance users: results from clinical and nonclinical samples.

Authors:  Michael Weinborn; Jonson Moyle; Romola S Bucks; Werner Stritzke; Angela Leighton; Steven Paul Woods
Journal:  J Int Neuropsychol Soc       Date:  2013-01-14       Impact factor: 2.892

Review 10.  An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research.

Authors:  Lisa R Norman; Michael Basso
Journal:  Curr Drug Abuse Rev       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.